IBM Watson Health collaborating with Brigham and Women’s Hospital and Vanderbilt on Medical AI
IBM Watson Health announced on 2/13/2019 plans to make a 10-year, $50 million investment in research collaborations with two separate academic centers – Brigham and Women’s Hospital, which is a teaching hospital of Harvard Medical School, and Vanderbilt University Medical Center – to advance the science of artificial intelligence (AI) and its application to major public health issues.
Related Posts
April 15, 2021
Cala Health Claims to Have the only Patented Neurostimulation for Essential Tremor Treatment. The Patent Data Disagrees
Cala Health has figured out that innovations backed by patents make them exponentially more valuable in the marketplace. However, in a zest…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Activity,AI Biotech / Diagnostics: Neurology
April 8, 2021
Capital One is Investing in AI Biotech? What’s in their wallet?
In the past 18 months, Capital One has expanded past its usual banking activities, and begun exploring the AI Biotech Sector. But do they…
April 1, 2021
Google AI Reinvents Speech Recognition. Who will follow?
There is no doubt that the big 5 tech companies (Apple, Amazon, Google, Facebook, and Microsoft) have developed massive IP portfolios in…
AI Biotech / Diagnostics,AI Biotech / Diagnostics: Neurology


